Literature DB >> 2356556

Cyclosporin treatment in rapidly progressive pulmonary thromboembolic Behçet's disease.

J F Vansteenkiste1, P Peene, J A Verschakelen, K P van de Woestijne.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2356556      PMCID: PMC473777          DOI: 10.1136/thx.45.4.295

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  8 in total

Review 1.  Pulmonary involvement in the collagen vascular diseases.

Authors:  G W Hunninghake; A S Fauci
Journal:  Am Rev Respir Dis       Date:  1979-03

2.  Behçet's syndrome with haemoptysis and pulmonary lesions.

Authors:  J D Davies
Journal:  J Pathol       Date:  1973-04       Impact factor: 7.996

3.  Thoracic manifestations of Behcet's syndrome.

Authors:  A G Decroix
Journal:  Thorax       Date:  1969-05       Impact factor: 9.139

4.  Recurrent pneumonia in Behçet's syndrome. Roentgenographic documentation during 13 years.

Authors:  T L Petty; C H Scoggin; J T Good
Journal:  JAMA       Date:  1977-12-05       Impact factor: 56.272

5.  Pulmonary involvement in Behcet disease.

Authors:  P Grenier; O Bletry; F Cornud; P Godeau; H Nahum
Journal:  AJR Am J Roentgenol       Date:  1981-09       Impact factor: 3.959

6.  Treatment of intraocular inflammatory disease with cyclosporin A.

Authors:  R B Nussenblatt; A G Palestine; A H Rook; I Scher; W B Wacker; I Gery
Journal:  Lancet       Date:  1983-07-30       Impact factor: 79.321

Review 7.  Pulmonary manifestations in Behçet's syndrome.

Authors:  I Raz; E Okon; T Chajek-Shaul
Journal:  Chest       Date:  1989-03       Impact factor: 9.410

8.  Takayasu arteritis: radiographic and angiographic findings in 59 patients.

Authors:  M Yamato; J W Lecky; K Hiramatsu; E Kohda
Journal:  Radiology       Date:  1986-11       Impact factor: 11.105

  8 in total
  1 in total

Review 1.  Pulmonary vasculitis: classification, clinical features, and management.

Authors:  A Ciaccia; M Ferrari; F M Facchini; G Caramori; L Fabbri
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.